About
IGL is a medical technology company based in France, founded in 2003. It specializes in the preservation of donor organs and tissues for transplantation. The company has developed several advanced solutions, including IGL-1®, a preservation solution for abdominal organs, and WAVES®, a transportable renal perfusion system. IGL has expanded its operations internationally, with subsidiaries in the USA and Latin America, and has acquired notable products like the CELSIOR® solution. In 2023, IGL launched the RM4, a two-kidney perfusion machine, and received CE marking for several of its products under the EU Medical Device Regulation. The company is committed to continuous improvement and expertise in organ preservation technology, aiming to enhance the success of transplantation procedures.
Technologies
Keywords
Company Information
-
Employees 450
-
Founded 2002
Location
Lissieu, Rhone-Alpes, France
